BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8267581)

  • 1. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin.
    Waga I; Nakamura M; Honda Z; Ferby I; Toyoshima S; Ishiguro S; Shimizu T
    Biochem Biophys Res Commun; 1993 Dec; 197(2):465-72. PubMed ID: 8267581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
    Chakrabarti R; Hubbard NE; Lim D; Erickson KL
    Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F; Decker K
    Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung.
    Honda Z; Nakamura M; Miki I; Minami M; Watanabe T; Seyama Y; Okado H; Toh H; Ito K; Miyamoto T
    Nature; 1991 Jan; 349(6307):342-6. PubMed ID: 1846231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hetrazepine PAF antagonists.
    Ikegami K; Meade CJ; Heuer HO; Birke F
    J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages.
    de Oliveira SI; Fernandes PD; Amarante Mendes JG; Jancar S
    Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):62-73. PubMed ID: 16846787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological regulation with platelet activating factor--molecular cloning and signal transduction of PAF].
    Izumi T; Shimizu T
    Rinsho Ketsueki; 1994 Apr; 35(4):386-9. PubMed ID: 8028185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of the guinea-pig lung platelet-activating factor receptor encoded by the cloned cDNA.
    Honda Z; Nakamura M; Seyama Y; Shimizu T
    J Lipid Mediat; 1992; 5(2):105-7. PubMed ID: 1326344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of macrophage responsiveness to platelet-activating factor by interferon-gamma and lipopolysaccharide.
    Howard AD; Erickson KL
    Cell Immunol; 1996 Dec; 174(2):155-64. PubMed ID: 8954615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute portal hypertension increases ileal vulnerability to platelet-activating factor in rats.
    Sakaguchi T; Nakamura S; Suzuki S; Oda T; Ichiyama A; Baba S
    J Surg Res; 1999 Sep; 86(1):116-22. PubMed ID: 10452877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of reversible priming of human neutrophils using platelet-activating factor.
    Kitchen E; Rossi AG; Condliffe AM; Haslett C; Chilvers ER
    Blood; 1996 Dec; 88(11):4330-7. PubMed ID: 8943870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM; Teixeira MM; Hellewell PG
    J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
    Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
    Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and properties of platelet-activating factor receptor cDNAs.
    Nakamura M; Honda Z; Matsumoto T; Noma M; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):163-8. PubMed ID: 8395240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.